Thanks to early detection and advances in treatment, breast cancer survival rates have improved significantly in recent years.
However, existing therapies have limited benefit if the disease metastasises or spreads to other sites in the body.
Breast cancer metastasis to the brain causes considerable morbidity and is inevitably fatal, with patients typically surviving four to eighteen months from diagnosis.
Researchers at UQ’s Faculty of Medicine are combining their world-leading expertise in a multifaceted approach to try to improve that outlook for patients.
